Systems biology of the metabolic network regulated by the Akt pathway

Biotechnology Advances

Volumn 30, Issue 1, 2012, Pages 131-141

  Mosca, Ettore ^a   Barcella, Matteo ^a   Alfieri, Roberta ^a   Bevilacqua, Annamaria ^b,c   Canti, Gianfranco ^c   Milanesi, Luciano ^a  

^a CNR   (Italy)

^b SECTION OF MATHEMATICS   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

Author keywords

Cancer; Glycolysis; Kinetic models; Metabolic network; PI3K Akt pathway; Systems biology

Indexed keywords

CANCER; GLYCOLYSIS; KINETIC MODELS; METABOLIC NETWORK; PI3K/AKT PATHWAY; SYSTEMS BIOLOGY;

ACTIVATION ANALYSIS; CELLS; DISEASES; KINETIC THEORY; TISSUE CULTURE;

METABOLISM;

PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B;

BIOMARKER; CANCER; ENZYME ACTIVITY; METABOLISM; REACTION KINETICS;

ANIMAL; BIOLOGICAL MODEL; ENERGY METABOLISM; ENZYMOLOGY; HUMAN; METABOLISM; NEOPLASM; REVIEW; SIGNAL TRANSDUCTION; SYSTEMS BIOLOGY;

ANIMALS; ENERGY METABOLISM; HUMANS; METABOLIC NETWORKS AND PATHWAYS; MODELS, BIOLOGICAL; NEOPLASMS; PHOSPHATIDYLINOSITOL 3-KINASES; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; SYSTEMS BIOLOGY;

EID: 84855740305     PISSN: 07349750     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biotechadv.2011.08.004     Document Type: Review

References (93)

1. Aki T., Yamaguchi K., Fujimiya T., Mizukami Y. Phosphoinositide 3-kinase accelerates autophagic cell death during glucose deprivation in the rat cardiomyocyte-derived cell line H9c2. Oncogene 2003, 22:8529-8535.
2. Alberghina L., Westerhoff H.V. Systems biology, definitions and perspectives 2005, Springer Verlag, Berlin Heidelberg.
3. Anderson A.R., Quaranta V. Integrative mathematical oncology. Nat Rev Cancer 2008, 8:227-234.
4. Asnaghi L., Calastretti A., Bevilacqua A., D'Agnano I., Gatti G., Canti G., et al. Bcl-2 phosphorylation and apoptosis activated by damaged microtubules require mTOR and are regulated by Akt. Oncogene 2004, 23:5781-5791.
5. Barman T.E. Enzyme handbook 1969, Springer-Verlag, Berlin.
6. Barthel A., Okino S.T., Liao J., Nakatani K., Li J., Whitlock J.P., et al. Regulation of GLUT1 gene transcription by the serine/threonine kinase Akt1. J Biol Chem 1999, 274:20281-20286.
7. Berwick D.C., Hers I., Heesom K.J., Moule S.K., Tavare J.M. The identification of ATP-citrate lyase as a protein kinase B (Akt) substrate in primary adipocytes. J Biol Chem 2002, 277:33895-33900.
8. Bizzarri M., Cucina A., Conti F., D'Anselmi F. Beyond the oncogene paradigm: understanding complexity in cancerogenesis. Acta Biotheor 2008, 56:173-196.
9. Boyer P.D. Pyruvate kinase. The enzymes 1962, Vol. 6:95-113. Academic Press, New York and London. P.D. Boyer, H. Lardy, K. Myrhack (Eds.).
10. Bruggeman F.J., Boogerd F.C., Westerhoff H.V. The multifarious short-term regulation of ammonium assimilation of Escherichia coli: dissection using an in silico replica. FEBS J 2005, 272:1965-1985.
11. Bruno P., Calastretti A., Priulla M., Asnaghi L., Scarlatti F., Nicolin A., et al. Cell survival under nutrient stress is dependent on metabolic conditions regulated by Akt and not by autophagic vacuoles. Cell Signal 2007, 19:2118-2126.
12. Burgering B.M., Coffer P.J. Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction. Nature 1995, 376:599-602.
13. Buzzai M., Bauer D.E., Jones R.G., Deberardinis R.J., Hatzivassiliou G., Elstrom R.L., et al. The glucose dependence of Akt-transformed cells can be reversed by pharmacologic activation of fatty acid beta-oxidation. Oncogene 2005, 24:4165-4173.
14. Calera M.R., Martinez C., Liu H., Jack A.K., Birnbaum M.J., Pilch P.F. Insulin increases the association of Akt-2 with Glut4-containing vesicles. J Biol Chem 1998, 273:7201-7204.
15. Carnero A., Blanco-Aparicio C., Renner O., Link W., Leal J.F. The PTEN/PI3K/Akt signalling pathway in cancer, therapeutic implications. Curr Cancer Drug Targets 2008, 8:187-198.
16. Chance B., Garfinkel D., Higgins J., Hess B. Metabolic control mechanisms. V. A solution for the equations representing interaction between glycolysis and respiration in ascites tumour cells. J Biol Chem 1960, 235:2426-2439.
17. Conant G.C., Wolfe K.H. Increased glycolytic flux as an outcome of whole-genome duplication in yeast. Mol Syst Biol 2007, 3:129.
18. Cox B.G., Hammes G.G. Steady-state kinetic study of fatty acid synthase from chicken liver. Proc Natl Acad Sci USA 1983, 80:4233-4237.
19. Cuellar A., Lloyd C., Nielsen P., Bullivant D., Nickerson D., Hunter P. An overview of CellML 1.1, a biological model description language. Simul 2003, 79:740-747.
20. DeBerardinis R.J., Cheng T. Q's next: the diverse functions of glutamine in metabolism, cell biology and cancer. Oncogene 2010, 29:313-324.
21. DeBerardinis R.J., Lum J.J., Thompson C.B. Phosphatidylinositol 3-kinase-dependent modulation of carnitine palmitoyltransferase 1A expression regulates lipid metabolism during hematopoietic cell growth. J Biol Chem 2006, 281:37372-37380.
22. DeBerardinis R.J., Sayed N., Ditsworth D., Thompson C.B. Brick by brick: metabolism and tumour cell growth. Curr Opin Genet Dev 2008, 18:54-61.
23. Deprez J., Vertommen D., Alessi D.R., Hue L., Rider M.H. Phosphorylation and activation of heart 6-phosphofructo-2-kinase by protein kinase B and other protein kinases of the insulin signalling cascades. J Biol Chem 1997, 272:17269-17275.
24. Edinger A.L., Thompson C.B. Akt maintains cell size and survival by increasing mTOR-dependent nutrient uptake. Mol Biol Cell 2002, 13:2276-2288.
25. Edwards J.S., Palsson B.Ø. Systems properties of the Haemophilus influenzae Rd metabolic genotype. J Biol Chem 1999, 274:17410-17416.
26. Elstrom R.L., Bauer D.E., Buzzai M., Karnauskas R., Harris M.H., Plas D.R., et al. Akt stimulates aerobic glycolysis in cancer cells. Cancer Res 2004, 64:3892-3899.
27. Engelman J.A. Targeting PI3K signalling in cancer: opportunities, challenges and limitations. Nat Rev Cancer 2009, 9:550-562.
28. Galazzo J.L., Bailey J.E. Fermentation pathway kinetics and metabolic flux control in suspended and immobilized Saccharomyces cerevisiae. Enz Microb Technol 1990, 12:162-172.
29. Garfinkel D., Hess B. Metabolic control mechanisms. VII. A detailed computer model of the glycolytic pathway in ascites cells. J Biol Chem 1964, 239:971-983.
30. Hall A.M., Smith A.J., Bernlohr D.A. Characterization of the Acyl-CoA synthetase activity of purified murine fatty acid transport protein 1. J Biol Chem 2003, 278:43008-43013.
31. Hanahan D., Weinberg R.A. The hallmarks of cancer. Cell 2000, 100:57-70.
32. Hanahan D., Weinberg R.A. The hallmarks of cancer: the next generation. Cell 2011, 144:646-674.
33. Haser W.G., Shapiro R.A., Curthoys N.P. Comparison of the phosphate-dependent glutaminase obtained from rat brain and kidney. Biochem J 1985, 229:399-408.
34. Hayden E. Cancer complexity slows quest for cure. Nature 2008, 455:148.
35. Heinrich R., Schuster S. The modelling of metabolic systems. Structure, control and optimality. Biosystems 1998, 47:61-77.
36. Henry O., Jolicoeur M., Kamen A. Unraveling the metabolism of HEK-293 cells using lactate isotopomer analysis. Bioprocess Biosyst Eng 2011, 34:263-273.
37. Herrgard M.J., Lee B.S., Portnoy V., Palsson B.Ø. Integrated analysis of regulatory and metabolic networks reveals novel regulatory mechanisms in Saccharomyces cerevisiae. Genome Res 2006, 16:627-635.
38. Holzhütter H.G. The principle of flux minimization and its application to estimate stationary fluxes in metabolic networks. Eur J Biochem 2004, 271:2905-2922.
39. Hornberg J.J., Bruggeman F.J., Westerhoff H.V., Lankelma J. Cancer: a systems biology disease. Biosystems 2006, 83:81-90.
40. Hsu P.P., Sabatini D.M. Cancer cell metabolism: Warburg and beyond. Cell 2008, 134:703-707.
41. Huang W.C., Hung M.C. Induction of Akt activity by chemotherapy confers acquired resistance. J Formos Med Assoc 2009, 108:180-194.
42. Hucka M., Finney A., Sauro H.M., Bolouri H., Doyle J.C., Kitano H., et al. The Systems Biology Markup Language (SBML): a medium for representation and exchange of biochemical network models. Bioinformatics 2003, 9:524-531.
43. Jiang N., Cox R.D., Hancock J.M. A kinetic core model of the glucose-stimulated insulin secretion network of pancreatic beta cells. Mamm Genome 2007, 18:508-520.
44. Kandel E.S., Hay N. The regulation and activities of the multifunctional serine/threonine kinase Akt/PKB. Exp Cell Res 1999, 253:210-229.
45. Kaushik V.K., Kavana M., Volz J.M., Weldon S.C., Hanrahan S., Xu J., et al. Characterization of recombinant human acetyl-CoA carboxylase-2 steady-state kinetics. Biochim Biophys Acta 2009, 1794:961-967.
46. Kohn A.D., Summers S.A., Birnbaum M.J., Roth R.A. Expression of a constitutively active Akt Ser/Thr kinase in 3T3-L1 adipocytes stimulates glucose uptake and glucose transporter 4 translocation. J Biol Chem 1996, 271:31372-31378.
47. Kreeger P.K., Lauffenburger D.A. Cancer systems biology: a network modeling perspective. Carcinogenesis 2010, 31:2-8.
48. Kroemer G. Mitochondria in cancer oncogene 2006, 25:4630-4632.
49. Lambeth M.J., Kushmerick M.J. A computational model for glucogenolysis in skeletal muscle. Ann Biomed Eng 2002, 30:808-827.
50. Laubenbacher R., Hower V., Jarrah A., Torti S.V., Shulaev V., Mendes P., et al. A systems biology view of cancer. Biochim Biophys Acta 2009, 1796:129-139.
51. Le Novère N., Finney A., Hucka M., Bhalla U.S., Campagne F., Collado-Vides J., et al. Minimum information requested in the annotation of biochemical models (MIRIAM). Nat Biotechnol 2005, 23:1509-1515.
52. Lee J.M., Gianchandani E.P., Eddy J.A., Papin J.A. Dynamic analysis of integrated signalling, metabolic, and regulatory networks. PLoS Comput Biol 2008, 4:e1000086.
53. Li C., Donizelli M., Rodriguez N., Dharuri H., Endler L., Chelliah V., et al. BioModels database: an enhanced, curated and annotated resource for published quantitative kinetic models. BMC Syst Biol 2010, 4:92.
54. LoPiccolo J., Granville C.A., Gills J.J., Dennis P.A. Targeting Akt in cancer therapy. Anticancer Drugs 2007, 18:861-874.
55. Lueck J.D., Fromm H.J. Kinetics, mechanism, and regulation of rat skeletal muscle hexokinase. J Biol Chem 1974, 249:1341-1347.
56. Majewski N., Nogueira V., Bhaskar P., Coy P.E., Skeen J.E., Gottlob K., et al. Hexokinase-mitochondria interaction mediated by Akt is required to inhibit apoptosis in the presence or absence of Bax and Bak. Mol Cell 2004, 16:819-830.
57. Manning B.D., Cantley L.C. AKT/PKB signalling: navigating downstream. Cell 2007, 129:1261-1274.
58. Marín-Hernández A., Gallardo-Pérez J.C., Rodríguez-Enríquez S., Encalada R., Moreno-Sánchez R., Saavedra E. Modeling cancer glycolysis. Biochim Biophys Acta 2011, 1807:755-767. Jun.
59. McIntyre L.M., Thorburn D.R., Bubb W.A., Kuchel P.W. Comparison of computer simulations of the F-type and L-type non-oxidative hexose monophosphate shunts with 31P-NMR experimental data from human erythrocytes. Eur J Biochem 1989, 180:399-420.
60. Moreno-Sánchez R., Rodríguez-Enríquez S., Marín-Hernández A., Saavedra E. Energy metabolism in tumour cells. FEBS J 2007, 274:1393-1418.
61. Moreno-Sánchez R., Saavedra E., Rodríguez-Enríquez S., Gallardo-Pérez J.C., Quezada H., Westerhoff H.V. Metabolic control analysis indicates a change of strategy in the treatment of cancer. Mitochondrion 2010, 10:626-639.
62. Mulquiney P.J., Kuchel P.W. Model of 2,3-bisphosphoglycerate metabolism in the human erythrocyte based on detailed enzyme kinetic equations: equations and parameter refinement. Biochem J 1999, 342:581-596.
63. Nazaret C., Heiske M., Thurley K., Mazat J.P. Mitochondrial energetic metabolism: a simplified model of TCA cycle with ATP production. J Theor Biol 2009, 258:455-464.
64. Nielsen K., Sørensen P.G., Hynne F., Busse H.G. Sustained oscillations in glycolysis: an experimental and theoretical study of chaotic and complex periodic behavior and of quenching of simple oscillations. Biophys Chem 1998, 72:49-62.
65. Oberhardt M.A., Palsson B.Ø., Papin J.A. Applications of genome-scale metabolic reconstructions. Mol Syst Biol 2009, 5:320.
66. Pastorino J.G., Hoek J.B. Regulation of hexokinase binding to VDAC. J Bioenerg Biomembr 2008, 40:171-182.
67. Pawson T., Warner N. Oncogenic re-wiring of cellular signalling pathways. Oncogene 2007, 26:1268-1275.
68. Pedersen P.L. The cancer cell's "power plants" as promising therapeutic targets: an overview. J Bioenerg Biomembr 2007, 39:1-12.
69. Plowman D.M., Cleland W.W. Purification and kinetic studies of the citrate cleavage enzyme. J Biol Chem 1967, 242:4239-4247.
70. Potapova I.A., El-Maghrabi M.R., Doronin S.V., Benjamin W.B. Phosphorylation of recombinant human ATP:citrate lyase by cAMP-dependent protein kinase abolishes homotropic allosteric regulation of the enzyme by citrate and increases the enzyme activity. Allosteric activation of ATP:citrate lyase by phosphorylated sugars. Biochemistry 2000, 39:1169-1179.
71. Rathmell J.C., Fox C.J., Plas D.R., Hammerman P.S., Cinalli R.M., Thompson C.B. Akt-directed glucose metabolism can prevent Bax conformation change and promote growth factor-independent survival. Mol Cell Biol 2003, 23:7315-7328.
72. Rizzi M., Baltes M., Theobald U., Reuss M. In vivo analysis of metabolic dynamics in Saccharomyces cerevisiae: II mathematical model. Biotechnol Bioeng 1997, 55:592-608.
73. Robey R.B., Hay N. Is Akt the "Warburg kinase"?-Akt-energy metabolism interactions and oncogenesis. Semin Cancer Biol 2009, 19:25-31.
74. Singh V.K., Ghosh I. Kinetic modeling of tricarboxylic acid cycle and glyoxylate bypass in Mycobacterium tuberculosis, and its application to assessment of drug targets. Theor Biol Med Model 2006, 3:27.
75. Snoep J.L. The silicon cell initiative: working towards a detailed kinetic description at the cellular level. Curr Opin Biotechnol 2005, 16:336-343.
76. Snoep J.L., Bruggeman F., Olivier B.G., Westerhoff H.V. Towards building the silicon cell: a modular approach. Biosystems 2006, 83:207-216.
77. Steib A., Rendon A., Mark J., Borg J. Preferential glutamine uptake in rat brain synaptic mitochondria. FEBS Lett 1986, 207:63-68.
78. Swierczyński J. Purification and some properties of extramitochondrial malic enzyme from rat skeletal muscle. Biochim Biophys Acta 1980, 616:10-21.
79. Teusink B., Passarge J., Reijenga C.A., Esgalhado E., Van der Weijden C.C., Schepper M., et al. Can yeast glycolysis be understood in terms of in vitro kinetics of the constituent enzymes? Testing biochemistry. Eur J Biochem 2000, 267:5313-5329.
80. Tokunaga E., Oki E., Egashira A., Sadanaga N., Morita M., Kakeji Y., et al. Deregulation of the Akt pathway in human cancer. Curr Cancer Drug Targets 2008, 8:27-36.
81. Tong X., Zhao F., Thompson C.B. The molecular determinants of de novo nucleotide biosynthesis in cancer cells. Curr Opin Genet Dev 2009, 19:32-37.
82. Vander Heiden M.G., Cantley L.C., Thompson C.B. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 2009, 324:1029-1033.
83. Wang E. A roadmap of cancer systems biology. Cancer systems biology. Chapman & hall/CRC mathematical and computational biology series 2010, 1-31. CRC Press. E. Wang (Ed.).
84. Warburg O. On the origin of cancer cells. Science 1956, 123:309-314.
85. Weinstein I.B. Disorders in cell circuitry during multistage carcinogenesis: the role of homeostasis. Carcinogenesis 2000, 21:857-864.
86. Welsh G.I., Hers I., Berwick D.C., Dell G., Wherlock M., Birkin R., et al. Role of protein kinase B in insulin-regulated glucose uptake. Biochem Soc Trans 2005, 33:346-349.
87. Wise D.R., Thompson C.B. Glutamine addiction: a new therapeutic target in cancer. Trends Biochem Sci 2010, 35:427-433.
88. Wise D.R., DeBerardinis R.J., Mancuso A., Sayed N., Zhang X.Y., Pfeiffer H.K., et al. Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction. Proc Natl Acad Sci USA 2008, 105:18782-18787.
89. Wu F., Yang F., Vinnakota K.C., Beard D.A. Computer modeling of mitochondrial tricarboxylic acid cycle, oxidative phosphorylation, metabolite transport, and electrophysiology. J Biol Chem 2007, 282:24525-24537.
90. Yeung S.J., Pan J., Lee M.H. Roles of p53, MYC and HIF-1 in regulating glycolysis-the seventh hallmark of cancer. Cell Mol Life Sci 2008, 65:3981-3999.
91. Young C.D., Anderson S.M. Sugar and fat-that's where it's at: metabolic changes in tumours. Breast Cancer Res 2008, 10:202.
92. Yugi K., Tomita M. A general computational model of mitochondrial metabolism in a whole organelle scale. Bioinformatics 2004, 20:1795-1796.
93. Yuneva M. Finding an "Achilles' heel" of cancer: the role of glucose and glutamine metabolism in the survival of transformed cells. Cell Cycle 2008, 7:2083-2089.